Toggle navigation
About
About us
Management Team
Board of Directors
Advisory Board
R&D
Immuno-oncology
Technology
Collaborations
Publications
Posters
Clinical program
Partnering
Investors
Overview
The share
Shareholder information
Nomination committee
Largest shareholders
Financial calendar
Reports & Presentations
Financial Reports
Presentations
Information Document
Events
Analyst coverage
IR Contact
National Prospectus 2024
News
Press releases & other news
Subscribe
Contact
post@lytixbiopharma.com
Investors |
Reports & Presentations |
Financial Reports
2024
Report
Presentation
Webcast
Interim - Q3 2024
Interim - Q2 2024
Interim - Q1 2024
2023
Report
Presentation
Webcast
Annual Report 2023
Interim - Q4 2023
Interim - Q3 2023
Interim - Q2 2023
Interim - Q1 2023
2022
Report
Presentation
Webcast
Annual report 2022
Interim - Q4 2022
Interim - Q3 2022
Interim - Q2 2022
Interim - Q1 2022
2021
Report
Presentation
Webcast
Annual report 2021
Interim - Q4 2021
Interim - Q3 2021
Interim - Q2 2021
2020
Report
Presentation
Webcast
Annual Report 2020
2019
Report
Presentation
Webcast
Annual Report 2019
2018
Report
Presentation
Webcast
Annual Report 2018
investors
Overview
The share
Shareholder information
Nomination committee
Largest shareholders
Financial calendar
Reports & Presentations
Financial Reports
Presentations
Information Document
Events
Analyst coverage
IR Contact
National Prospectus 2024